The new director of AESIA discovers CiTIUS during the institution’s second visit to the center this year
Alberto Gago Fernández, director of the Spanish Agency for the Supervision of Artificial Intelligence, visited the USC research center on a day marked by the launch of a training program on artificial intelligence applied to health, promoted by the CAMELIA Chair.
CiTIUS today received an institutional visit from Alberto Gago Fernández, the new director of the Spanish Artificial Intelligence Supervision Agency (AESIA). The day provided an opportunity to present first-hand some of the main research lines of the center and to strengthen the dialogue between the state agency responsible for overseeing the development of artificial intelligence in Spain and one of the leading centers in this field in Galicia.
During his stay at the center, the director of AESIA learned about various projects and scientific capabilities of CiTIUS in areas such as machine learning, robotics and advanced data analysis, on a tour accompanied by the center’s scientific director, Senén Barro, and deputy director, Paula López.
The institutional agenda also coincided with the opening of a training initiative aimed at leaders in the healthcare sector, jointly organized by the Galicia Health Cluster and the USC-Plexus Chair of Artificial Intelligence in Personalized Precision Medicine (CAMELIA). The program, entitled “Artificial Intelligence in Health: Fundamentals, Regulation and Real Applications for Decision-Making,” seeks to offer a strategic vision of the use of artificial intelligence in healthcare, addressing its technological foundations as well as its regulatory framework and its ethical and organizational implications.
The first session of the program was held at the CiTIUS facilities and featured the participation of the AESIA director himself, who shared his vision of the role of the agency in supervising the development and deployment of artificial intelligence systems in Spain, as well as the challenges posed by their adoption in particularly sensitive areas such as health.
In this context, Alberto Gago Fernández also highlighted the role that Galicia is acquiring in the development and supervision of artificial intelligence in Spain. “It is no coincidence that AESIA is in Galicia, nor that the European AI factory in health that has recently been awarded will be headquartered in Santiago,” said the director of the agency, who also recalled that the Government of Spain is financing approximately half of the 82 million euros allocated to this strategic project. This commitment, he explained, seeks to provide Galicia with the necessary resources to promote artificial intelligence at the service of businesses and citizens.
The head of AESIA also stressed the role that the agency intends to play in facilitating the safe adoption of these technologies by the business community. “At AESIA we provide support so that companies can incorporate this technology into their products with full guarantees for people. That is why we are developing a controlled testing environment, and one of the strategic lines will be health. Here companies will be able to test that their AI systems comply with the European Artificial Intelligence Regulation before they go to market.”
The visit helped to strengthen the dialogue between AESIA and the artificial intelligence research ecosystem that is taking shape in Galicia. In this context, CiTIUS (a center co-financed by the European Union through the Galicia Feder 2021-2027 Program) continues to consolidate its role as one of the research hubs specialized in artificial intelligence in Spain and as a space connecting scientific research, technological innovation and the real-world application of these technologies in strategic sectors such as health.
CiTIUS today received an institutional visit from Alberto Gago Fernández, the new director of the Spanish Artificial Intelligence Supervision Agency (AESIA). The day provided an opportunity to present first-hand some of the main research lines of the center and to strengthen the dialogue between the state agency responsible for overseeing the development of artificial intelligence in Spain and one of the leading centers in this field in Galicia.
During his stay at the center, the director of AESIA learned about various projects and scientific capabilities of CiTIUS in areas such as machine learning, robotics and advanced data analysis, on a tour accompanied by the center’s scientific director, Senén Barro, and deputy director, Paula López.
The institutional agenda also coincided with the opening of a training initiative aimed at leaders in the healthcare sector, jointly organized by the Galicia Health Cluster and the USC-Plexus Chair of Artificial Intelligence in Personalized Precision Medicine (CAMELIA). The program, entitled “Artificial Intelligence in Health: Fundamentals, Regulation and Real Applications for Decision-Making,” seeks to offer a strategic vision of the use of artificial intelligence in healthcare, addressing its technological foundations as well as its regulatory framework and its ethical and organizational implications.
The first session of the program was held at the CiTIUS facilities and featured the participation of the AESIA director himself, who shared his vision of the role of the agency in supervising the development and deployment of artificial intelligence systems in Spain, as well as the challenges posed by their adoption in particularly sensitive areas such as health.
In this context, Alberto Gago Fernández also highlighted the role that Galicia is acquiring in the development and supervision of artificial intelligence in Spain. “It is no coincidence that AESIA is in Galicia, nor that the European AI factory in health that has recently been awarded will be headquartered in Santiago,” said the director of the agency, who also recalled that the Government of Spain is financing approximately half of the 82 million euros allocated to this strategic project. This commitment, he explained, seeks to provide Galicia with the necessary resources to promote artificial intelligence at the service of businesses and citizens.
The head of AESIA also stressed the role that the agency intends to play in facilitating the safe adoption of these technologies by the business community. “At AESIA we provide support so that companies can incorporate this technology into their products with full guarantees for people. That is why we are developing a controlled testing environment, and one of the strategic lines will be health. Here companies will be able to test that their AI systems comply with the European Artificial Intelligence Regulation before they go to market.”
The visit helped to strengthen the dialogue between AESIA and the artificial intelligence research ecosystem that is taking shape in Galicia. In this context, CiTIUS (a center co-financed by the European Union through the Galicia Feder 2021-2027 Program) continues to consolidate its role as one of the research hubs specialized in artificial intelligence in Spain and as a space connecting scientific research, technological innovation and the real-world application of these technologies in strategic sectors such as health.